Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 14,508 $ 4,801
Prepaid expenses and other current assets 6,904 6,887
Current portion of restricted cash 60 30
Total current assets 21,472 11,718
Property and equipment, net 421 572
Restricted cash, less current portion 248 60
Other assets 10,651 13,401
Total assets 32,792 25,751
Current liabilities:    
Accounts payable 816 15,486
Accrued expenses 1,829 12,458
Derivative liability 28,865  
Current portion of long-term debt 6,374 5,800
Current portion of royalty-linked notes 114  
Other current liabilities 3,598 3,042
Income taxes payable 102 200
Total current liabilities 41,698 36,986
Long-term debt, less current portion 22,462 7,625
Royalty-linked notes, less current portion 13,389  
Other liabilities 5,802 7,378
Total liabilities 83,351 51,989
Commitments and contingencies (Note 13)
Shareholders’ deficit:    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at December 31, 2020 and December 31, 2019; no shares issued at December 31, 2020 and December 31, 2019
Ordinary shares, $0.01 par value per share: 150,000,000 shares authorized, 49,431,028 shares issued at December 31, 2020; 50,000,000 shares authorized, 14,868,973 shares issued at December 31, 2019 494 149
Additional paid-in capital 235,876 208,536
Accumulated deficit (286,929) (234,923)
Total shareholders' deficit (50,559) (26,238)
Total liabilities and shareholders’ deficit $ 32,792 $ 25,751